Form 4: Scholar Rock CFO Sinha Boosts Equity Holdings

Scholar Rock Holding Corp's Chief Financial Officer, Vikas Sinha, acquired 47,021 restricted stock units, aligning executive interests with long-term company performance.

Summary

• Vikas Sinha, Chief Financial Officer of Scholar Rock Holding Corp (SRRK), acquired 47,021 Restricted Stock Units (RSUs).
• The transaction date for this acquisition was February 9, 2026.
• These RSUs are subject to time-based vesting conditions, with each RSU representing the contingent right to receive one share of the Issuer's common stock upon vesting.
• The shares will vest in four annual installments over four years, with the first installment on January 15, 2027, and subsequent installments annually thereafter, provided Mr. Sinha maintains a service relationship with the Issuer.
• Following this transaction, Mr. Sinha beneficially owns a total of 630,266 securities, comprising 33,245 shares of common stock, 147,021 time-based RSUs, and 450,000 performanceand time-based RSUs.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with long-term company performance and retention.

Positives

• The acquisition of 47,021 RSUs by the Chief Financial Officer indicates continued alignment of management's interests with long-term shareholder value.
• The time-based vesting schedule over four years encourages executive retention and sustained focus on company performance.

Negatives

• The issuance of RSUs, upon vesting, will result in a minor dilutive effect on existing shareholders as new shares are issued.

Risks

• The vesting of the RSUs is contingent upon the reporting person continuing to have a service relationship with Scholar Rock Holding Corp on each vesting date.

Future Outlook

The vesting schedule for the RSUs extends over four years, with the first installment in January 2027, indicating a long-term commitment and incentive structure for the Chief Financial Officer.

Management Comments

• "Represents restricted stock units ('RSUs') subject to time-based vesting conditions."
• "Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."
• "The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2027 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date."

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units (RSUs) to key executives like the CFO is a standard practice in the biotechnology and pharmaceutical industries. This form of equity compensation is widely used to attract, retain, and incentivize top talent, aligning their long-term interests with shareholder value creation, particularly in companies with long development cycles like Scholar Rock.

Comparison to Industry Standards

• The RSU grant to Scholar Rock's CFO is consistent with executive compensation practices observed across the biotech sector, where equity-based incentives are a primary component of total compensation.
• Companies such as Moderna (MRNA) and BioNTech (BNTX) frequently utilize RSU grants with multi-year vesting schedules to retain key scientific and management personnel, similar to the four-year vesting period seen here.
• The structure, linking vesting to continued service, is a common mechanism to ensure executive commitment, mirroring practices at peers like Regeneron Pharmaceuticals (REGN) and Vertex Pharmaceuticals (VRTX).

Stakeholder Impact

• Shareholders: Potential minor dilution upon RSU vesting, but improved alignment of executive interests with long-term company performance.
• Employees: Standard executive compensation practices can positively influence overall employee morale and retention strategies.

Next Steps

• First annual installment of RSU vesting on January 15, 2027.
• Subsequent annual RSU vesting installments over the following three years, contingent on continued service.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a key executive, which is a standard compensation practice. While it signals management's continued commitment, it does not present new information significant enough to warrant a change in investment recommendation based solely on this filing. It's an expected event that aligns executive incentives but doesn't fundamentally alter the company's financial outlook or strategic position.

Keywords

Scholar Rock Holding Corp, SRRK, Vikas Sinha, Chief Financial Officer, CFO, Restricted Stock Units, RSUs, insider transaction, executive compensation, equity award, vesting